Biography
Dr Malczewski is committed to patient centred care with an interest in applying the latest developments in chemotherapy, targeted therapy and immunotherapy. She understands the importance of clear communication with her patients and their loved ones.
Dr Agnieszka Malczewski is a medical oncologist based at Icon Wesley, Chermside and Northlakes. After graduating from James Cook University, Townsville in 2005 with a Bachelor of Medicine, Bachelor of Surgery (Hons 1) and the University Medal, she completed her oncology training in Brisbane in 2012 with rotations through the Princess Alexandra and the Royal Brisbane and Women’s Hospitals.
Between 2012-2013, she completed her fellowship in early phase clinical trials and melanoma at the University of Oxford in the United Kingdom, where she was involved in clinical and laboratory based research. Dr Malczewski became a fellow the Royal Australian College of Physicians in 2013.
Dr Malczewski has experience treating a broad range of solid tissue tumours, including melanoma, tumours of the gastrointestinal tract (pancreatic, gastric, colorectal cancer), urogenital tumours such as bladder, kidney and prostate cancer, lung cancer, breast and ovarian cancer. She has special interest in immuno-oncology and the microbiome.
In 2019, Dr Malczewski was awarded a Master of Science with Distinction, through the University of Oxford. Her thesis focused on the clinical presentation of melanoma in Queensland. She is currently completing her PhD in metabolomics in melanoma and has been awarded a 2021 clinical innovation grant through Uniting Care Health to fund her project, which is a collaborative effort between Uniting Care Health, QIMR and the University of New England.
She has interests in medical research and attends both the Wesley Medical Research Committee and the Icon Cancer Care Research Committee. She is the principal investigator for several melanoma and pancreatic cancer trials and authors Pancreatic Cancer Reviews. She is committed to teaching in medicine and holds the appointment of senior lecturer with the University of Queensland.
Publications
Enhancing Checkpoint Inhibitor Therapy in Solid Tissue Cancers: The Role of Diet, the Microbiome & Microbiome-Derived Metabolites. Malczewski AB, Ketheesan N, Coward JIG, Navarro S. 2021 Jul;12. Frontiers in Immunology, 2021:624434.
Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy. Malczewski AB, Navarro S, Coward JI, Ketheesan N. 2020 Oct;8(20). Journal for ImmunoTherapy of Cancer, 2020:e001383.
Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trials. Malczewski A, Marshall A, Payne MJ, Mao L, Bafaloukos D, Si L, Pectasides D, Fountzilas G, Guo J, Gogas H, Middleton MR. Cancer Med. 2016 Jan;5(1):17-23.
Clinical presentation of melioidosis in Queensland, Australia. Malczewski AB, Oman KM, Norton RE, Ketheesan N. Trans R Soc Trop Med Hyg. 2005 Nov;99(11):856-60.
Effect of cryopreservation on the immunogenicity of umbilical cord blood cells. Ketheesan N, Whiteman C, Malczewski AB, Hirst RG, La Brooy JT. Transfus Apher Sci. 2004 Feb;30(1):47-54.